SEGMENT INFORMATION - Schedule of Information About Reported Segment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
REVENUE AND DEFERRED REVENUE
Revenue	$ 74,890	$ 71,348	$ 65,206
Cost of revenues	20,729	19,643	15,483
Segment Gross profit	54,161	51,705	49,723
Research and development	12,771	9,515	9,336
Loss from operations	(34,563)	(30,554)	(35,111)
Interest expense	7,286	5,424	4,251
Loss on extinguishment of debt	4,427
Other income, net	(2,549)	(5,789)	(2,203)
Net loss	(43,727)	(30,189)	(37,159)
Medical Device
REVENUE AND DEFERRED REVENUE
Revenue	74,890	71,348	65,206
Cost of revenues	20,729	19,643	15,483
Segment Gross profit	54,161	51,705	49,723
Personnel	44,938	50,530	55,143
Marketing	8,373	9,217	8,952
Research and development	2,720	3,849	3,834
Professional fees	10,929	6,231	5,921
Other segment expenses	$ 21,764	$ 12,432	$ 10,984
Segment Reporting Other Item Composition Description	Other segment expenses include travel and entertainment, bad debt, depreciation and amortization, insurance, rent, and other costs.	Other segment expenses include travel and entertainment, bad debt, depreciation and amortization, insurance, rent, and other costs.	Other segment expenses include travel and entertainment, bad debt, depreciation and amortization, insurance, rent, and other costs.
Loss from operations	$ (34,563)	$ (30,554)	$ (35,111)